Skip to main content
. Author manuscript; available in PMC: 2014 Jun 12.
Published in final edited form as: J Clin Psychiatry. 2013 Mar;74(3):226–232. doi: 10.4088/JCP.12m07853

TABLE 3. Suicide Risk Assessment and Provider Actions at the Final VHA Visit.

Provider Action Patients Dying by
Suicide
(n=244)
Matched
Comparison
Patients
(n=244)
Number of
Discordant
Pairsa
P valueb
N % N % N / N
Suicidal Ideation Assessed 73d 29.9d 49d 20.1d 57/33 0.01
 Suicidal Ideation
 Endorsed (among
 Assessed Patients)
11
(of 73)
15.1 2
(of 49)
4.1 11/2 0.07c
Suicidal Plan Assessed 17 7.0 6 2.5 17/6 0.02
 Suicidal Plan Endorsed
 (among Assessed
 Patients)
4
(of 17)
23.5 0
(of 6)
0 4/0 0.54c
Safety Planning conducted 13 5.3 3 1.2 13/3 0.01
Access to Means Assessed 6 2.5 3 1.2 6/3 0.32
Hospitalization Considered 3 1.4e 1 0.4e 3/1 0.32
a

Discordant pairs reported as Number of matched pairs in which Patient Dying by Suicide Assessed (or Action taken) but Comparison patient not assessed (or no action)/Number of matched pairs in which Patient Dying by Suicide Not Assessed (or No Action Taken) but Comparison Patient Assessed (or Action taken).

b

All p-values are from McNemar’s test except where noted.

c

p-values based on Fisher’s exact test.

d

Counts and rates of assessment of suicidal ideation for subsample restricted to the 157 patients dying by suicide and the 161 comparison patients with a current depression diagnosis (Major Depression or Depression NOS) or current antidepressant use at final visit are: 63 patients, 40.1% (patients dying by suicide) and 42 patients, 26.1% (comparison patients). Both rates are statistically different at p=0.0012 or less from the rates for patients without current diagnoses or antidepressant use. P value for the comparison between patients dying by suicide and comparison patients equals 0.009 (Fisher’s exact test).

e

Does not include the 22 patients dying by suicide and 5 comparison patients who were inpatient at the time of their last final assessment, since they were already hospitalized.